RELAX-REPEAT: a multicentre, prospective, randomised, double-blind study evaluating the safety and tolerability of repeat doses of serelaxin in patients with chronic heart failure.

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late Breaking Trials I: Focus on acute heart failure Acute Heart Failure HFA Premium Access HEART FAILURE 2016

ESC 365 is supported by

ESC 365 is supported by